8AP-11205-39982
4 vaccinations
4 coded responses
49 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 220 / VA
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
32Q-26199-29459
Child or adolescent in my care · Male · 2022-07-14
HDM-31300-67351
Child or adolescent in my care · Female · 2022-07-14
U6H-28416-16757
Child or adolescent in my care · Female · 2022-07-14
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Pfizer-BioNTech
- 2021-03-18
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-03-20
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Fair · Site: PainFree text: Swollen lymph nodes in armpitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Swollen lymph nodes in armpitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-22
- 2021-03-24
- 2021-03-25
- 2021-04-01
-
2021-04-08
Dose 2 — Pfizer-BioNTech
- 2021-04-08
-
2021-04-10
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Swollen lymph nodes in armpitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-07-08
- 2021-10-07
-
2021-10-12
Dose 3 — Pfizer-BioNTech
- 2021-10-12
- 2021-10-13
-
2021-10-14
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-10-15
- 2021-10-16
- 2021-10-17
- 2021-10-18
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-11-18
- 2021-11-23
- 2022-01-11
-
2022-04-12
Survey response — 6 months, dose 3MedDRA: COVID-19, Cough, Ear pain, Headache, Respiratory tract congestion, Sneezing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid-19 congestion, headache, sneezing, ear pain, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-09-19
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-22
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2022-09-23
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-12-20
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech | |
| 3 | 2021-10-12 | Pfizer-BioNTech | No |
| 4 | 2022-09-19 | Pfizer-BioNTech | Flu |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Swollen lymph nodes in armpit
Systemic reaction (other): Swollen lymph nodes in armpit
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes in armpit
Release 11 — 6 months, dose 3
Symptoms: Covid-19 congestion, headache, sneezing, ear pain, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Ear pain | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release